The Three COVID-19 Treatments: Vaccine, Antibody, And Inhibitor

Coronavirus disease (COVID-19) as a severe contagion induces the international public health emergency. Millions of people have been infected or died. The whole society affected because of the suspending of work. To deal with this situation, scientist did studies and research on various kinds of treatments. Among those, vaccine, antibody and inhibitor are three common treatments for COVID-19. Vaccines, by mimicking the infection of external pathogens but with lower pathogenicity, help the host establish long-term protection, which is the key prophylactic strategy. Antibody, the product of immune response, is taken as the treatment after infection. Inhibitor, usually small molecules or enzymatic analogues, aims to interfere with the functions of viral enzyme and disrupt the life cycle of virus. In this review, we conducted a thorough investigation by literature reviewing, illustrating the definition, components and mechanisms of these three treatments, besides, some specific approved drugs in the corresponding categories are also presented.

Authors

Institutions

Publication Details

Journal
Highlights in Science Engineering and Technology
Published
2024-12-24
DOI
https://doi.org/10.54097/7y0bdc26
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Three COVID-19 Treatments: Vaccine, Antibody, And Inhibitor

Huixin Xie
Highlights in Science Engineering and Technology
SARS-CoV-2 and COVID-19 Research
article

The Three COVID-19 Treatments: Vaccine, Antibody, And Inhibitor

Huixin Xie
article en

Abstract

Coronavirus disease (COVID-19) as a severe contagion induces the international public health emergency. Millions of people have been infected or died. The whole society affected because of the suspending of work. To deal with this situation, scientist did studies and research on various kinds of treatments. Among those, vaccine, antibody and inhibitor are three common treatments for COVID-19. Vaccines, by mimicking the infection of external pathogens but with lower pathogenicity, help the host establish long-term protection, which is the key prophylactic strategy. Antibody, the product of immune response, is taken as the treatment after infection. Inhibitor, usually small molecules or enzymatic analogues, aims to interfere with the functions of viral enzyme and disrupt the life cycle of virus. In this review, we conducted a thorough investigation by literature reviewing, illustrating the definition, components and mechanisms of these three treatments, besides, some specific approved drugs in the corresponding categories are also presented.

Highlights in Science Engineering and TechnologyVol. 123
Momoyama Gakuin University (JP)
Openalex Percentile: Top 70%
SARS-CoV-2 and COVID-19 Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.